Enzene Biosciences announces India launch of colorectal cancer drug Bevacizumab https://ift.tt/tpJb54w

During the launch of Bevacizumab, a biosimilar of Avastin, Dr Himanshu Gadgil, CEO, Enzene Biosciences Ltd stated that one of the problems they were trying to solve was to disrupt the cost barriers in the biosimilars market because India has been developing biosimilars for quite some time but the affordability has remained a big concern.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TY6CWON
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.